- Home
- SIEB vs FENC Comparison
SIEB vs FENC Comparison
Compare SIEB & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- FENC
- Stock Information
- Founded
- SIEB 1886
- FENC 1996
- Country
- SIEB United States
- FENC United States
- Employees
- SIEB N/A
- FENC N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIEB Finance
- FENC Health Care
- Exchange
- SIEB Nasdaq
- FENC Nasdaq
- Market Cap
- SIEB 148.8M
- FENC 156.9M
- IPO Year
- SIEB N/A
- FENC 2001
- Fundamental
- Price
- SIEB $5.29
- FENC $7.95
- Analyst Decision
- SIEB
- FENC Strong Buy
- Analyst Count
- SIEB 0
- FENC 2
- Target Price
- SIEB N/A
- FENC $13.00
- AVG Volume (30 Days)
- SIEB 138.3K
- FENC 105.2K
- Earning Date
- SIEB 05-13-2025
- FENC 05-13-2025
- Dividend Yield
- SIEB N/A
- FENC N/A
- EPS Growth
- SIEB 117.05
- FENC N/A
- EPS
- SIEB 0.46
- FENC N/A
- Revenue
- SIEB $92,064,000.00
- FENC $30,912,000.00
- Revenue This Year
- SIEB N/A
- FENC N/A
- Revenue Next Year
- SIEB N/A
- FENC $58.65
- P/E Ratio
- SIEB $11.91
- FENC N/A
- Revenue Growth
- SIEB 21.82
- FENC N/A
- 52 Week Low
- SIEB $1.41
- FENC $3.96
- 52 Week High
- SIEB $5.53
- FENC $8.56
- Technical
- Relative Strength Index (RSI)
- SIEB 72.90
- FENC 66.93
- Support Level
- SIEB $3.56
- FENC $7.79
- Resistance Level
- SIEB $4.62
- FENC $8.34
- Average True Range (ATR)
- SIEB 0.50
- FENC 0.46
- MACD
- SIEB 0.10
- FENC 0.06
- Stochastic Oscillator
- SIEB 87.74
- FENC 76.75
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.